TB-500 vs GHK-Cu

Side-by-side comparison of TB-500, GHK-Cu — mechanism, dosing, half-life, side effects, and research status.

← Pick different peptides
Attribute TB-500 Thymosin Beta-4 Synthetic Analogue Recovery GHK-Cu Glycyl-L-Histidyl-L-Lysine Copper Complex Recovery
Basics
Molecular type Thymic Peptide AnalogueCopper-Binding Tripeptide
Amino acids 433
Molecular weight 4,921 Da340.4 Da
Half-life Long-acting (days)Short (minutes to hours)
Route(s) Subcutaneous, IntramuscularSubcutaneous, Topical (skin), IV (research)
Mechanism & Research
Primary mechanism TB-500's primary mechanism involves binding to G-actin (monomeric actin) through its conserved LKKTETQ sequence. By sequestering actin, it regulates cytoskeletal dynamics in ways that promote cell migration — a critical … GHK-Cu forms a stable complex with copper(II), which is essential for its biological activity. The copper complex activates collagenase and other metalloproteinases that remodel damaged extracellular matrix while simulta…
Research status Research Compound Research Compound
Evidence summary TB-500 research spans cardiac regeneration, wound healing, hair follicle regeneration, and musculoskeletal repair. Most data is preclinical. Phase 1/2 trials with native Thymosin Beta-4 for cardiac indications have been … GHK-Cu is one of the most thoroughly researched cosmetic and wound-healing peptides. Topical GHK-Cu is commercially used in skincare. Deeper systemic applications (anti-aging, neuroprotection, systemic collagen support) …
Protocol & Dosing
Typical dose 5–10 mg per injection1–2 mg/day (SC); topical as needed
Frequency 2x per week (loading), then weeklyDaily
Duration 4–8 weeks8–12 weeks
Timing No specific timing requirementAny time of day
Safety
Common side effects
  • Injection site reaction
  • Mild fatigue (transient)
  • Headache
  • Lethargy in first days
  • Topical: mild skin irritation at application site
  • Injectable: injection site redness
  • Copper taste (topical — rare)
Contraindications
  • Active cancer (angiogenic activity)
  • Pregnancy
  • Platelet disorders or anticoagulant use
  • Wilson's disease (copper metabolism disorder)
  • Known copper sensitivity
  • Pregnancy (insufficient systemic safety data)
Anti-doping Prohibited (WADA S2) Not Prohibited
Deeper reading
Related peptides BPC-157, GHK-Cu, Thymosin Alpha-1 BPC-157, Epithalon, LL-37
Full profile Read full TB-500 profile → Read full GHK-Cu profile →

Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.